Owens & Minor
- Home ›
- US ›
- Healthcare
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. The last earnings update was 51 days ago. More info.
Add to Portfolio Compare Print
- Owens & Minor has significant price volatility in the past 3 months.
OMI Share Price and Events
7 Day Returns
1 Year Returns
OMI Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Owens & Minor (OMI) | 1.5% | -17.5% | -54.9% | -78.7% | -90.6% | -89.4% |
| US Healthcare | 1.8% | -5.2% | -9.7% | -2.8% | 13.1% | 63.8% |
| US Market | 0.9% | 4.6% | 10.9% | 9.6% | 39% | 47.2% |
1 Year Return vs Industry and Market
- OMI underperformed the Healthcare industry which returned -2.8% over the past year.
- OMI underperformed the Market in United States of America which returned 9.6% over the past year.
Value
Is Owens & Minor undervalued based on future cash flows and its price relative to the stock market?
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Owens & Minor
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Owens & Minor.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 9 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 14.7% |
| Perpetual Growth Rate | 10-Year US Government Bond Rate | 2.7% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year US Govt Bond Rate | 2.7% |
| Equity Risk Premium | S&P Global | 6% |
| Healthcare Unlevered Beta | Simply Wall St/ S&P Global | 0.72 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.716 (1 + (1- 21%) (766.76%)) |
3.715 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
2 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (2 * 5.96%) |
14.65% |
Discounted Cash Flow Calculation for NYSE:OMI using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Owens & Minor is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (USD, Millions) | Source |
Present Value Discounted (@ 14.65%) |
|
|---|---|---|---|
| 2019 | 69.57 | Analyst x4 | 60.68 |
| 2020 | 69.51 | Analyst x4 | 52.88 |
| 2021 | 73.00 | Analyst x1 | 48.44 |
| 2022 | 75.20 | Est @ 3.02% | 43.52 |
| 2023 | 77.41 | Est @ 2.93% | 39.08 |
| 2024 | 79.63 | Est @ 2.87% | 35.06 |
| 2025 | 81.88 | Est @ 2.83% | 31.45 |
| 2026 | 84.17 | Est @ 2.8% | 28.20 |
| 2027 | 86.51 | Est @ 2.78% | 25.28 |
| 2028 | 88.90 | Est @ 2.76% | 22.66 |
| Present value of next 10 years cash flows | $387.24 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2028
× (1 + g) ÷ (Discount Rate – g)
= $88.90 × (1 + 2.73%) ÷ (14.65% – 2.73%) |
$766.19 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= $766.19 ÷ (1 + 14.65%)10 |
$195.25 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= $387.24 + $195.25 |
$582.49 |
| Equity Value per Share (USD) |
= Total value / Shares Outstanding
= $582.49 / 63.02 |
$9.24 |
| Calculation | Result | |
|---|---|---|
| Value per share (USD) | From above. | $9.24 |
| Current discount | Discount to share price of
$3.43
= -1 x ($3.43 - $9.24) / $9.24 |
62.9% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
Current Discount
Current Discount Checks
- Owens & Minor's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Owens & Minor's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Owens & Minor's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Owens & Minor's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-12-31) in USD | $-7.28 |
| NYSE:OMI Share Price ** | NYSE (2019-04-25) in USD | $3.43 |
| United States of America Healthcare Industry PE Ratio | Median Figure of 53 Publicly-Listed Healthcare Companies | 21.81x |
| United States of America Market PE Ratio | Median Figure of 3,081 Publicly-Listed Companies | 18.28x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Owens & Minor.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = NYSE:OMI Share Price ÷ EPS (both in USD) = 3.43 ÷ -7.28 |
-0.47x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Owens & Minor is loss making, we can't compare its value to the US Healthcare industry average.
- Owens & Minor is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does
Owens & Minor's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | -0.47x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 9 Analysts |
134.8%per year |
| United States of America Healthcare Industry PEG Ratio | Median Figure of 40 Publicly-Listed Healthcare Companies | 1.52x |
| United States of America Market PEG Ratio | Median Figure of 2,113 Publicly-Listed Companies | 1.57x |
*Line of best fit is calculated by linear regression .
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to calculate PEG ratio for Owens & Minor, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on
Owens & Minor's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-12-31) in USD | $8.32 |
| NYSE:OMI Share Price * | NYSE (2019-04-25) in USD | $3.43 |
| United States of America Healthcare Industry PB Ratio | Median Figure of 92 Publicly-Listed Healthcare Companies | 2.39x |
| United States of America Market PB Ratio | Median Figure of 5,185 Publicly-Listed Companies | 1.92x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = NYSE:OMI Share Price ÷ Book Value per Share (both in USD) = 3.43 ÷ 8.32 |
0.41x |
* Primary Listing of Owens & Minor.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Owens & Minor is good value based on assets compared to the US Healthcare industry average.
Value checks
We assess Owens & Minor's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check) Owens & Minor has a total score of 3/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
Future Performance
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Owens & Minor's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
- Owens & Minor's earnings growth is expected to exceed the United States of America market average.
- Owens & Minor's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| NYSE:OMI Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 9 Analysts | 134.8% |
| NYSE:OMI Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 9 Analysts | 0.4% |
| United States of America Healthcare Industry Earnings Growth Rate | Market Cap Weighted Average | 13.3% |
| United States of America Healthcare Industry Revenue Growth Rate | Market Cap Weighted Average | 7.2% |
| United States of America Market Earnings Growth Rate | Market Cap Weighted Average | 13.5% |
| United States of America Market Revenue Growth Rate | Market Cap Weighted Average | 7.1% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 9 Analyst Estimates (S&P Global) | See Below |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-12-31 | ||||
| 2022-12-31 | ||||
| 2021-12-31 | 9,987 | 134 | 28 | 4 |
| 2020-12-31 | 9,867 | 117 | 2 | 9 |
| 2019-12-31 | 9,877 | 121 | 3 | 9 |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-12-31 | 9,839 | 116 | -437 |
| 2018-09-30 | 9,686 | 174 | -153 |
| 2018-06-30 | 9,555 | 186 | -141 |
| 2018-03-31 | 9,362 | 101 | 61 |
| 2017-12-31 | 9,318 | 57 | 72 |
| 2017-09-30 | 9,297 | 49 | 76 |
| 2017-06-30 | 9,378 | 62 | 95 |
| 2017-03-31 | 9,596 | 116 | 102 |
| 2016-12-31 | 9,723 | 188 | 108 |
| 2016-09-30 | 9,843 | 208 | 113 |
| 2016-06-30 | 9,899 | 66 | 111 |
| 2016-03-31 | 9,838 | 146 | 108 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 9 Analyst Estimates (S&P Global) | See Below |
All data from Owens & Minor Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-12-31 | ||||
| 2022-12-31 | ||||
| 2021-12-31 | 0.45 | 0.45 | 0.45 | 1.00 |
| 2020-12-31 | 0.08 | 0.34 | -0.35 | 3.00 |
| 2019-12-31 | 0.14 | 0.23 | 0.05 | 2.00 |
| Date (Data in USD Millions) | EPS * |
|---|---|
| 2018-12-31 | -7.28 |
| 2018-09-30 | -2.54 |
| 2018-06-30 | -2.36 |
| 2018-03-31 | 1.02 |
| 2017-12-31 | 1.20 |
| 2017-09-30 | 1.26 |
| 2017-06-30 | 1.57 |
| 2017-03-31 | 1.69 |
| 2016-12-31 | 1.76 |
| 2016-09-30 | 1.83 |
| 2016-06-30 | 1.80 |
| 2016-03-31 | 1.74 |
*GAAP earnings excluding extraordinary items.
Future performance checks
We assess Owens & Minor's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Owens & Minor has a total score of 3/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
Past Performance
How has Owens & Minor performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Owens & Minor does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- Unable to compare Owens & Minor's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Unable to compare Owens & Minor's 1-year growth to the US Healthcare industry average as it is not currently profitable.
Earnings and Revenue History
All data from Owens & Minor Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-12-31 | 9,838.71 | -437.01 | 1,261.75 | |
| 2018-09-30 | 9,685.56 | -152.52 | 1,184.97 | |
| 2018-06-30 | 9,554.65 | -141.35 | 1,119.41 | |
| 2018-03-31 | 9,362.28 | 61.02 | 1,063.65 | |
| 2017-12-31 | 9,318.28 | 71.73 | 1,016.98 | |
| 2017-09-30 | 9,296.80 | 75.87 | 978.83 | |
| 2017-06-30 | 9,378.44 | 94.81 | 959.09 | |
| 2017-03-31 | 9,596.21 | 102.33 | 965.39 | |
| 2016-12-31 | 9,723.43 | 107.64 | 970.42 | |
| 2016-09-30 | 9,842.98 | 112.59 | 977.12 | |
| 2016-06-30 | 9,899.05 | 110.97 | 982.77 | |
| 2016-03-31 | 9,837.54 | 107.56 | 986.81 | |
| 2015-12-31 | 9,772.95 | 102.48 | 993.78 | |
| 2015-09-30 | 9,776.85 | 84.57 | 987.76 | |
| 2015-06-30 | 9,691.31 | 63.70 | 972.18 | |
| 2015-03-31 | 9,575.00 | 59.39 | 951.06 | |
| 2014-12-31 | 9,440.18 | 65.91 | 984.10 | |
| 2014-09-30 | 9,266.89 | 79.81 | 904.87 | |
| 2014-06-30 | 9,151.31 | 100.54 | 884.84 | |
| 2014-03-31 | 9,081.53 | 109.54 | 871.55 | |
| 2013-12-31 | 9,071.53 | 110.14 | 863.66 | |
| 2013-09-30 | 9,038.11 | 107.16 | 853.03 | |
| 2013-06-30 | 8,947.46 | 103.82 | 807.00 | |
| 2013-03-31 | 8,896.83 | 105.03 | 744.74 | |
| 2012-12-31 | 8,868.32 | 108.25 | 682.60 | |
| 2012-09-30 | 8,779.11 | 107.24 | 621.72 | |
| 2012-06-30 | 8,775.98 | 115.89 | 609.22 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- It is difficult to establish if Owens & Minor has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- It is difficult to establish if Owens & Minor has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.
- It is difficult to establish if Owens & Minor improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
Past performance checks
We assess Owens & Minor's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Owens & Minor has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
Health
How is Owens & Minor's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Owens & Minor's finances.
The net worth of a company is the difference between its assets and liabilities.
- Owens & Minor is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Owens & Minor's cash and other short term assets cover its long term commitments.
Balance sheet
Assets
Liabilities and shares
- High level of physical assets or inventory.
- Debt is covered by short term assets, assets are 1.5x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Owens & Minor Company Filings, last reported 3 months ago.
| Date (Data in USD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-12-31 | 518.42 | 1,657.46 | 103.37 |
| 2018-09-30 | 792.41 | 1,640.46 | 124.89 |
| 2018-06-30 | 802.21 | 1,669.48 | 118.19 |
| 2018-03-31 | 1,018.92 | 897.07 | 87.63 |
| 2017-12-31 | 1,015.48 | 900.74 | 104.52 |
| 2017-09-30 | 1,003.78 | 917.26 | 98.42 |
| 2017-06-30 | 993.57 | 579.12 | 57.07 |
| 2017-03-31 | 969.96 | 564.15 | 127.17 |
| 2016-12-31 | 960.04 | 564.58 | 185.49 |
| 2016-09-30 | 986.68 | 566.47 | 213.10 |
| 2016-06-30 | 996.30 | 566.96 | 138.95 |
| 2016-03-31 | 1,004.92 | 567.71 | 190.32 |
| 2015-12-31 | 992.59 | 568.50 | 161.02 |
| 2015-09-30 | 986.10 | 574.03 | 125.25 |
| 2015-06-30 | 977.13 | 574.62 | 200.97 |
| 2015-03-31 | 968.27 | 574.61 | 159.06 |
| 2014-12-31 | 990.84 | 608.55 | 56.77 |
| 2014-09-30 | 1,007.52 | 766.28 | 610.15 |
| 2014-06-30 | 1,031.39 | 219.10 | 92.03 |
| 2014-03-31 | 1,033.17 | 214.83 | 182.37 |
| 2013-12-31 | 1,025.04 | 216.24 | 101.91 |
| 2013-09-30 | 1,006.32 | 214.42 | 153.79 |
| 2013-06-30 | 989.82 | 214.68 | 207.83 |
| 2013-03-31 | 977.55 | 214.24 | 218.56 |
| 2012-12-31 | 973.66 | 217.59 | 97.89 |
| 2012-09-30 | 960.06 | 214.80 | 79.67 |
| 2012-06-30 | 949.96 | 212.03 | 224.94 |
- Owens & Minor's level of debt (319.7%) compared to net worth is high (greater than 40%).
- The level of debt compared to net worth has increased over the past 5 years (21.1% vs 319.7% today).
- Debt is not well covered by operating cash flow (7%, less than 20% of total debt).
- Owens & Minor is making a loss, therefore interest payments are not well covered by earnings.
Financial health checks
We assess Owens & Minor's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Owens & Minor has a total score of 2/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
Dividends
What is Owens & Minor's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
$2,000 of
Owens & Minor
shares you are expected to receive
$6
in your first year as a dividend.
Dividend Amount
- Owens & Minor's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.39%).
- Owens & Minor's dividend is below the markets top 25% of dividend payers in United States of America (3.61%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 9 Analyst Estimates (S&P Global) | See Below |
| United States of America Healthcare Industry Average Dividend Yield | Market Cap Weighted Average of 21 Stocks | 1.6% |
| United States of America Market Average Dividend Yield | Market Cap Weighted Average of 2008 Stocks | 2.4% |
| United States of America Minimum Threshold Dividend Yield | 10th Percentile | 0.8% |
| United States of America Bottom 25% Dividend Yield | 25th Percentile | 1.4% |
| United States of America Top 25% Dividend Yield | 75th Percentile | 3.6% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in $) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2023-12-31 | ||
| 2022-12-31 | ||
| 2021-12-31 | 0.28 | 4.00 |
| 2020-12-31 | 0.20 | 7.00 |
| 2019-12-31 | 0.01 | 5.00 |
| Date (Data in $) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2019-02-19 | 0.010 | 0.225 |
| 2018-11-05 | 0.300 | 4.049 |
| 2018-10-31 | 0.300 | 3.392 |
| 2018-08-07 | 1.040 | 6.585 |
| 2018-05-10 | 1.040 | 6.136 |
| 2018-01-31 | 1.040 | 6.505 |
| 2017-11-01 | 1.030 | 5.261 |
| 2017-08-01 | 1.030 | 3.661 |
| 2017-05-04 | 1.030 | 3.212 |
| 2017-02-14 | 1.030 | 2.961 |
| 2016-11-01 | 1.020 | 2.925 |
| 2016-08-02 | 1.020 | 3.011 |
| 2016-05-05 | 1.020 | 2.778 |
| 2016-02-08 | 1.020 | 2.621 |
| 2015-10-27 | 1.010 | 2.816 |
| 2015-07-27 | 1.010 | 2.956 |
| 2015-04-29 | 1.010 | 2.986 |
| 2015-02-17 | 1.010 | 2.963 |
| 2014-10-27 | 1.000 | 2.895 |
| 2014-07-28 | 1.000 | 2.989 |
| 2014-05-01 | 1.000 | 2.928 |
| 2014-02-10 | 1.000 | 2.871 |
| 2013-11-04 | 0.960 | 2.633 |
| 2013-07-29 | 0.960 | 2.709 |
| 2013-04-25 | 0.960 | 2.813 |
| 2013-02-11 | 0.960 | 3.057 |
| 2012-10-18 | 0.880 | 3.032 |
| 2012-07-18 | 0.880 | 3.045 |
| 2012-04-26 | 0.880 | 3.014 |
| 2012-02-06 | 0.880 | 2.943 |
| 2011-10-20 | 0.800 | 2.734 |
| 2011-07-21 | 0.800 | 2.736 |
| 2011-04-28 | 0.800 | 2.350 |
| 2011-02-07 | 0.800 | 2.524 |
| 2010-10-21 | 0.708 | 2.432 |
| 2010-07-23 | 0.708 | 2.581 |
| 2010-04-29 | 0.708 | 2.413 |
| 2010-04-26 | 0.708 | 2.236 |
| 2010-02-08 | 0.707 | 2.306 |
| 2009-10-21 | 0.613 | 2.221 |
| 2009-07-22 | 0.613 | 2.054 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Owens & Minor is not paying a notable dividend for United States of America, therefore no need to check if the payments are stable.
- Owens & Minor is not paying a notable dividend for United States of America, therefore no need to check if the payments are increasing.
Income/ dividend checks
We assess Owens & Minor's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Owens & Minor afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Owens & Minor has a total score of 1/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
Management
CEO
| AGE | 50 |
| TENURE AS CEO | 0.1 years |
CEO Bio
Mr. Edward A. Pesicka, also known as Ed, has been the Chief Executive Officer, President and Director of Owens & Minor, Inc. since March 4, 2019. Mr. Pesicka served as Chief Commercial Officer of Thermo Fisher Scientific, Inc. from January 2014 and as its Senior Vice President from July 2008 to March 31, 2015. Mr. Pesicka served as the President of Customer Channels at Thermo Fisher Scientific, Inc. from July 2008 to January 2014. He served as the President of Research Market of Thermo Fisher Scientific, Inc. from November 2006 to July 2008. He served as Vice President and General Manager of U.S. research business at Thermo Fisher from January 2004 to November 2006. Mr. Pesicka served as a Director at Dionex Corp. from 2011 to May 17, 2011. He holds an Master’s of Business Administration degree in finance from the Weatherhead School of Management at Case Western Reserve University and a Bachelor’s degree in accounting and business administration from Muskingum College.
CEO Compensation
- Insufficient data for Ed to compare compensation growth.
- Insufficient data for Ed to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure
Average tenure and age of the Owens & Minor management team in years:
- The average tenure for the Owens & Minor management team is less than 2 years, this suggests a new team.
Management Team
Robert Snead
Executive VP & CFO
$1M
41
0.8 yrs
Nick Pace
Executive VP
$2M
47
3.3 yrs
Chris Lowery
President of Global Products
$4M
54
0.3 yrs
Ed Pesicka
President
50
0.1 yrs
Mike Lowry
Senior VP
$311K
56
0.8 yrs
Joseph Pekala
Senior VP & Chief Information Officer
47
0.3 yrs
Erika Davis
Senior VP & Chief Administrative Officer
$1M
54
2.5 yrs
Chuck Graves
Director of Finance & Investor Relations
Jenny Graves
Vice President of Global Corporate Communications
Shana Neal
Senior VP & Chief Human Resources Officer
51
1.1 yrs
Board of Directors Tenure
Average tenure and age of the Owens & Minor board of directors in years:
- The tenure for the Owens & Minor board of directors is about average.
Board of Directors
Bob Sledd
Chairman
$3M
65
0.4 yrs
Ed Pesicka
President
50
0.1 yrs
G. Minor
Chairman Emeritus
$367K
77
6 yrs
Craig Smith
Chairman Emeritus
$45K
66
Lem Lewis
Independent Director
$269K
71
7.9 yrs
Martha Marsh
Independent Director
$264K
69
6.5 yrs
Barbara Hill
Independent Director
$256K
66
2.2 yrs
Anne Whittemore
Lead Independent Director
$281K
71
5.3 yrs
Eddie Moore
Independent Director
$248K
70
14 yrs
John Gerdelman
Independent Director
$245K
65
8.5 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price ($) | Value ($) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 28. Aug 18 | Sell | Charles Colpo | Individual | 27. Aug 18 | 27. Aug 18 | -11,000 | $16.87 | $-185,614 | ||
| 23. Aug 18 | Sell | Erika Davis | Individual | 21. Aug 18 | 21. Aug 18 | -10,000 | $16.59 | $-165,857 | ||
| 23. Aug 18 | Sell | Geoffrey Marlatt | Individual | 21. Aug 18 | 21. Aug 18 | -11,405 | $16.27 | $-185,559 | ||
| 22. Aug 18 | Sell | Erika Davis | Individual | 20. Aug 18 | 20. Aug 18 | -12,500 | $16.25 | $-203,063 | ||
| 21. Aug 18 | Sell | Charles Colpo | Individual | 20. Aug 18 | 20. Aug 18 | -12,000 | $16.31 | $-195,720 | ||
| 17. Aug 18 | Sell | Geoffrey Marlatt | Individual | 16. Aug 18 | 16. Aug 18 | -8,516 | $15.50 | $-132,015 | ||
Management checks
We assess Owens & Minor's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Owens & Minor has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
News
Simply Wall St News
Who Has Been Selling Owens & Minor, Inc. (NYSE:OMI) Shares?
So shareholders might well want to know whether insiders have been buying or selling shares in Owens & Minor, Inc. … But logic dictates you should pay some attention to whether insiders are buying or selling shares. … Owens & Minor Insider Transactions Over The Last Year
Simply Wall St - – Full articleIs It Too Late To Consider Buying Owens & Minor, Inc. (NYSE:OMI)?
As a stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock? … However, could the stock still be trading at a relatively cheap price. … Let’s examine Owens & Minor’s valuation and outlook in more detail to determine if there’s still a bargain opportunity
Simply Wall St - – Full articleWhy Owens & Minor, Inc.’s (NYSE:OMI) Return On Capital Employed Might Be A Concern
Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires. … Understanding Return On Capital Employed (ROCE). … ROCE measures the amount of pre-tax profits a company can generate from the capital employed in its business.
Simply Wall St - – Full articleOne Thing To Remember About The Owens & Minor, Inc. (NYSE:OMI) Share Price
(NYSE:OMI), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. … Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). … A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market.
Simply Wall St - – Full articleShould Owens & Minor Inc (NYSE:OMI) Be Part Of Your Income Portfolio?
Historically, Owens & Minor Inc (NYSE:OMI) has been paying a dividend to shareholders. … Let's take a look at Owens & Minor in more detail. … Check out our latest analysis for Owens & Minor
Simply Wall St - – Full articleWhy Owens & Minor Inc (NYSE:OMI) Could Be Worth Watching
Owens & Minor Inc (NYSE:OMI), which is in the healthcare business, and is based in United States,. … A question to answer is whether Owens & Minor's current trading price of $14.2 reflective of the actual value of the? … Let’s take a look at Owens & Minor’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change
Simply Wall St - – Full articleCheck If Insiders Are Selling Owens & Minor Inc (NYSE:OMI)
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare services company in the United States, the United Kingdom, Ireland, France, Germany, and other European countries. … Owens & Minor's insiders have divested from. … A well-known argument is that insiders divesting from their own companies’ shares sends a pessimistic signal
Simply Wall St - – Full articleWhat Are Analysts Saying About the future of Owens & Minor Inc's (NYSE:OMI)?
Owens & Minor Inc (NYSE:OMI) to … earnings growth of 33.82% annualised … it's necessary to take a moment
Simply Wall St - – Full articleOwens & Minor Inc (NYSE:OMI): What Does It Mean For Your Portfolio?
Generally, an investor should consider two types of risk that impact the market value of OMI. … The second type is market risk, one that you cannot diversify away, since it arises from macroeconomic factors which directly affects all the stocks in the market. … A widely-used metric to measure a stock's market risk is beta, and the broad market index represents a beta value of one.
Simply Wall St - – Full articleWith An ROE Of 6.10%, Has Owens & Minor Inc's (NYSE:OMI) Management Done Well?
and want to better understand how you can grow your money by investing in Owens & Minor Inc (NYSE:OMI). … Owens & Minor Inc (NYSE:OMI) generated a below-average return on equity of 6.10% in the past 12 months, while its industry returned 13.80%. … Knowing these components can change your views on OMI's below-average returns
Simply Wall St - – Full articleCompany Info
Description
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; various programs to provide logistics and marketing solutions to its suppliers; and contract logistics services to the pharmaceutical, biotechnology, and medical device industries offering a range of supply chain logistics services to manufacturers. In addition, it offers business services comprising order-to-cash, re-labeling, customer service, and returns management; and warehousing and transportation services consisting of storage, controlled-substance handling, cold-chain, emergency and export delivery, inventory management, and pick and pack services. The Global Products segment manufactures and sources medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. Its products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. The company provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians’ practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Mechanicsville, Virginia.
Details
| Name: | Owens & Minor, Inc. |
| OMI | |
| Exchange: | NYSE |
| Founded: | 1882 |
| $216,164,499 | |
| 63,021,720 | |
| Website: | http://www.owens-minor.com |
| Address: |
Owens & Minor, Inc. 9120 Lockwood Boulevard, Mechanicsville, Virginia, 23116, United States |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| NYSE | OMI | Common Stock | New York Stock Exchange | US | USD | 14. Dec 1972 | |
| DB | 6OM | Common Stock | Deutsche Boerse AG | DE | EUR | 14. Dec 1972 |
Number of employees
Current staff
Industry
| Health Care Distributors | |
| Healthcare |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/04/26 01:42 |
| End of day share price update: | 2019/04/25 00:00 |
| Last estimates confirmation: | 2019/04/23 |
| Last earnings filing: | 2019/03/06 |
| Last earnings reported: | 2018/12/31 |
| Last annual earnings reported: | 2018/12/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
